[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:ewing-sarcoma:cd276-wt-allele":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Ewing Sarcoma","CD276 wt Allele",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04897321","B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)",[12],"Phase 1","RECRUITING","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.511090Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07222735","Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed\u002FRefractory Sarcomas",[12],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:27.273704Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[12],"2026-08-26T02:18:49.989941Z","2026-07-19T19:36:05.081790Z"]